BCM
MR

BlueCrest Capital Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

BlueCrest Capital Management’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-35,000
Closed -$998K – 1146
2015
Q2 		$998K Buy
+35,000
New +$1.02M 0.03% 499

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
HP
Holowesko Partners Nassau, Bahamas $357M AUM 15.03% 1-Year Est. Return

BlueCrest Capital Management's MR Position: Q3 2015 in Review

BlueCrest Capital Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q3 2015, closing a stake of 35,000 shares — an estimated $998K sold.

BlueCrest Capital Management first reported a position in MR in Q2 2015 and held it in 1 quarter. The position peaked at $998K in Q2 2015. 105 funds tracked by Wall St. Rank hold MR as of Q3 2015.

  • BlueCrest Capital Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q3 2015 after selling out during the quarter.
  • BlueCrest Capital Management sold 35,000 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q3 2015, an estimated $998K.
  • BlueCrest Capital Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2015 and held it in 1 quarter.
  • BlueCrest Capital Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $998K in Q2 2015.
  • 105 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q3 2015.

Based on BlueCrest Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.